Literature DB >> 19051005

Endometrial receptivity is preserved in Diethylstilbestrol-associated and other Müllerian anomalies: evidence from tubal embryo transfer.

Eliran Mor1, Melanie Landay, Richard J Paulson.   

Abstract

PURPOSE: To report implantation and pregnancy rates following TET in women with anomalous uteri, and to compare these with previously reported rates following trans-cervical ET.
MATERIALS AND METHODS: Between 1995 and 2003, 12 TET procedures were performed in seven women with Müllerian anomalies. Tubal ET was performed via laparoscopy 48 h after standard IVF in 3 cycles in two patients, whereas in 9 cycles in five patients, TET was performed 24 h or 48 h following oocyte donation.
RESULTS: Of the seven patients, 5 (71%) had a history of 15 failed cycles with trans-cervical ET. The 12 TET procedures resulted in eleven clinical pregnancies (92%; 95% CI: 63, 99%). There were seven deliveries/ongoing pregnancies (58%; 95% CI: 27%, 85%).
CONCLUSIONS: We observed high implantation and ongoing pregnancy rates in women with Müllerian anomalies, suggesting that 1) endometrial receptivity in anomalous uteri is preserved, and 2) transfer efficiency is reduced but may be restored with the use of TET.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19051005      PMCID: PMC2649335          DOI: 10.1007/s10815-008-9281-7

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  11 in total

1.  Uterine anomalies and in vitro fertilization: what are the results?

Authors:  N Lavergne; J Aristizabal; V Zarka; R Erny; B Hedon
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1996-09       Impact factor: 2.435

2.  Incidence of Müllerian defects in fertile and infertile women.

Authors:  P Acién
Journal:  Hum Reprod       Date:  1997-07       Impact factor: 6.918

3.  Is tubal embryo transfer of any value? A meta-analysis and comparison with the Society for Assisted Reproductive Technology database.

Authors:  A E Habana; S F Palter
Journal:  Fertil Steril       Date:  2001-08       Impact factor: 7.329

4.  Effect of in-utero diethylstilboestrol exposure on human oocyte quality and fertilization in a programme of in-vitro fertilization.

Authors:  A Kerjean; C Poirot; S Epelboin; P Jouannet
Journal:  Hum Reprod       Date:  1999-06       Impact factor: 6.918

5.  Effects of Mullerian anomalies on in vitro fertilization outcome.

Authors:  K I Attia; M Hug-Koronya; E S Ginsburg; M D Hornstein
Journal:  J Assist Reprod Genet       Date:  2001-10       Impact factor: 3.412

6.  Outcome of IVF in DES-exposed daughters: experience in the 90s.

Authors:  L Pal; J L Shifren; K B Isaacson; Y Chang; M Marean; L Leykin; T L Toth
Journal:  J Assist Reprod Genet       Date:  1997-10       Impact factor: 3.412

7.  Assisted reproduction in women with uterine anomalies.

Authors:  P K Heinonen; K Kuismanen; R Ashorn
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2000-04       Impact factor: 2.435

8.  Endometrial pattern in diethylstilboestrol-exposed women undergoing in-vitro fertilization may be the most significant predictor of pregnancy outcome.

Authors:  N Noyes; H C Liu; K Sultan; Z Rosenwaks
Journal:  Hum Reprod       Date:  1996-12       Impact factor: 6.918

9.  Experience with diethylstilbestrol-exposed infertile women in a program of in vitro fertilization.

Authors:  S J Muasher; J E Garcia; H W Jones
Journal:  Fertil Steril       Date:  1984-07       Impact factor: 7.329

10.  Are implantation and pregnancy outcome impaired in diethylstilbestrol-exposed women after in vitro fertilization and embryo transfer?

Authors:  V C Karande; R G Lester; S J Muasher; D L Jones; A A Acosta; H W Jones
Journal:  Fertil Steril       Date:  1990-08       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.